PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.280
-0.060 (-4.48%)
At close: Jul 20, 2026, 4:00 PM EDT
1.262
-0.018 (-1.41%)
Pre-market: Jul 21, 2026, 7:38 AM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $68.26 million as of July 21, 2026. Its market cap has decreased by -1.20% in one year.
Market Cap
68.26M
Enterprise Value
-24.99M
1-Year Change
-1.20%
Ranking
Category
Stock Price
$1.28
ChartMarket Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $68.26M, a decrease of -95.77%. That is a compound annual growth rate of -41.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 68.26M | 2.63% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OKYO Pharma | 71.90M |
| Annovis Bio | 71.90M |
| LeonaBio | 71.11M |
| MindWalk Holdings | 71.02M |
| Gain Therapeutics | 69.53M |
| Gossamer Bio | 68.93M |
| XBiotech | 68.60M |
| iBio, Inc. | 68.06M |